Literature DB >> 32246886

COVID-19 transmission through asymptomatic carriers is a challenge to containment.

Xingxia Yu1, Rongrong Yang2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32246886      PMCID: PMC7228388          DOI: 10.1111/irv.12743

Source DB:  PubMed          Journal:  Influenza Other Respir Viruses        ISSN: 1750-2640            Impact factor:   4.380


× No keyword cloud information.
To the Editor, Since the first report on the outbreak of a novel coronavirus disease COVID‐19 in Wuhan, Hubei, China, in December, 2019, there have been 78 064 cases have been confirmed and 2715 deaths as of February 25, 2020. For any infectious disease, there are three kinds of way to control the epidemic of infectious disease‐that is, to control the source of infection, to cut off transmission routes, and to protect the susceptible population. As a new infectious disease, it is difficult to develop a safe and effective vaccine against COVID‐19 in a short period of time. So, it is not possible to protect susceptible population at present. Social distancing is one of the main ways to cut off transmission routes – people cannot pass on infection if they do not come into contact with other people. Based on the understanding that COVID‐19 spreads through respiratory droplets, there has been widespread use of face masks in Wuhan. The propaganda "no masks, no going outside" has been adopted by the public. This can help to cut off the transmission routes of COVID‐19. Increases in capacity for laboratory testing, allowing treatment and isolation of COVID‐19 patients also helps to reduce onwards transmission. In the period of initial success for COVID‐19 control and prevention, one bottleneck has been screening out asymptomatic carriers for reducing new infections. As frontline doctors, we believe that there have been asymptomatic carriers of COVID‐19 who can infect their close contacts. Although asymptomatic patients with SARS were uncommon, they were documented in a retrospective study in the minor 2004 SARS outbreak after reopening of the wildlife market in Guangzhou. Similarly, during the epidemic of COVID‐19 in Wuhan, one asymptomatic child (aged 10 years) who had a history of travel to Wuhan from Shenzhen was described in the report about a family cluster of COVID‐19. He had radiological ground‐glass lung opacities, and he was RT‐PCR positive for genes encoding the internal RNA‐dependent RNA polymerase and surface spike protein of this novel coronavirus, which were confirmed by Sanger sequencing. The child was virologically confirmed to have an asymptomatic infection. In addition, another family of three who travelled from Wuhan to Guangzhou was reported to be infected with COVID‐19. The father had clinical symptoms, a decreased lymphocyte count, abnormal chest CT images, and a positive result on qRT‐PCR. It's interesting that the mother and the son were both asymptomatic, with normal lymphocyte counts and chest CT images but positive qRT‐PCR for COVID‐19 infection. In both cases, asymptomatic carriers were diagnosed by screening after other family members developed symptoms. We presume there would be many other asymptomatic carriers who were never tested. Even if those carriers were in the hospital, perhaps for another reason, would the doctor think of doing a viral nucleic acid test for COVID‐19 in time? If it is not possible to screen these asymptomatic carriers from truly healthy populations, they will be a source of COVID‐19 infection back into the community, which will also pose a huge challenge for COVID‐19 prevention and control. On February 25, the case of COVID‐19 transmission occurring in a prison in Rencheng district, Jining city, Shandong province has sounded an alarm for us. On February 9, a man was released from prison and returned home. But he was informed to isolate himself because a prison officer was confirmed to have COVID‐19 infection on February 14. In order to avoid isolation and observation, the man absconded from his home. Later, it was confirmed that this man was an asymptomatic carrier, and his brother who had close contact with him became infected with COVID‐19. This case is an example of asymptomatic transmission. One study has reported that the viral load that was detected in the asymptomatic patients was similar to that in the symptomatic patients, which also theoretically suggests the potential transmission of asymptomatic patients. In Conclusion, we considered that asymptomatic COVID‐19 infection is possible, and person‐to‐person transmission can occur from asymptomatic COVID‐19 carriers to the community. Therefore, vigilant control measures are warranted at this stage of the COVID‐19 epidemic to avoid a resurgence in cases.

CONFLICT OF INTEREST

We declare no competing interests.

Author Contribution

Xingxia Yu: Conceptualization (equal); Data curation (equal); Formal analysis (equal); Investigation (equal); Methodology (equal); Project administration (equal); Resources (equal); Software (equal); Supervision (equal); Validation (equal); Visualization (equal); Writing‐original draft (equal); Writing‐review & editing (equal). Rongrong Yang: Conceptualization (equal); Data curation (equal); Formal analysis (equal); Investigation (equal); Methodology (equal); Project administration (equal); Resources (equal); Software (equal); Supervision (equal); Validation (equal); Visualization (equal); Writing‐original draft (equal); Writing‐review & editing (equal).
  5 in total

1.  A patient with asymptomatic severe acute respiratory syndrome (SARS) and antigenemia from the 2003-2004 community outbreak of SARS in Guangzhou, China.

Authors:  Xiao-yan Che; Biao Di; Guo-ping Zhao; Ya-di Wang; Li-wen Qiu; Wei Hao; Ming Wang; Peng-zhe Qin; Yu-fei Liu; Kwok-hong Chan; Vincent C C Cheng; Kwok-yung Yuen
Journal:  Clin Infect Dis       Date:  2006-05-18       Impact factor: 9.079

2.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

3.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

4.  SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients.

Authors:  Lirong Zou; Feng Ruan; Mingxing Huang; Lijun Liang; Huitao Huang; Zhongsi Hong; Jianxiang Yu; Min Kang; Yingchao Song; Jinyu Xia; Qianfang Guo; Tie Song; Jianfeng He; Hui-Ling Yen; Malik Peiris; Jie Wu
Journal:  N Engl J Med       Date:  2020-02-19       Impact factor: 91.245

5.  Asymptomatic cases in a family cluster with SARS-CoV-2 infection.

Authors:  Xingfei Pan; Dexiong Chen; Yong Xia; Xinwei Wu; Tangsheng Li; Xueting Ou; Liyang Zhou; Jing Liu
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071

  5 in total
  94 in total

1.  Antibiotic Choice: The Synergistic Effect of Single vs Dual Antibiotics.

Authors:  Nequesha S Mohamed; Wayne A Wilkie; Ethan A Remily; James Nace; Ronald E Delanois; James A Browne
Journal:  J Arthroplasty       Date:  2020-03       Impact factor: 4.757

2.  CT Scanning in Suspected Stroke or Head Trauma: Is it Worth Going the Extra Mile and Including the Chest to Screen for COVID-19 Infection?

Authors:  R M Kwee; J Krdzalic; B A C M Fasen; T M H de Jaegere
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-21       Impact factor: 3.825

3.  Seroprevalence of Sars-Cov-2 antibodies among eligible blood donors of Peshawar, Pakistan.

Authors:  Muhammad Nisar Khan; Haleema Khan; Muhammad Shahzad; Muhammad Ibrahim; Muhammad Arif; Zeeshan Kibria; Usman Waheed; Noore Saba; Inayat Shah; Yasar Mehmood Yousafzai
Journal:  Am J Blood Res       Date:  2022-06-20

4.  Clinical characteristics associated with long-term viral shedding in patients with coronavirus disease 2019.

Authors:  Miao Zhou; Fei-Fei Yu; Li Tan; Yu-Dan Zhu; Ning Ma; Li-Jun Song; Qi Li; Yang Liu; Zui Zou; Tian-Ying Xu; Chao Yu
Journal:  Am J Transl Res       Date:  2020-10-25       Impact factor: 4.060

Review 5.  COVID-19 and the immune system.

Authors:  J Paces; Z Strizova; D Smrz; J Cerny
Journal:  Physiol Res       Date:  2020-05-29       Impact factor: 1.881

6.  A SARS-CoV-2 familial cluster infection reveals asymptomatic transmission to children.

Authors:  Ming Chen; Panpan Fan; Zhi Liu; Rui Pan; Shaowu Huang; Junhua Li; Dongchi Zhao
Journal:  J Infect Public Health       Date:  2020-05-27       Impact factor: 3.718

7.  Complexities in viral replication strategies as a potential explanation for prevalence of asymptomatic carriers in Covid-19 infections: analytical observation on SARS-Cov2 genome characteristics.

Authors:  Himanshu Priyadarshi; Rekha Das
Journal:  Theory Biosci       Date:  2021-06-10       Impact factor: 1.919

8.  Dealing with COVID-19 Epidemic in Italy: Responses from Regional Organizational Models during the First Phase of the Epidemic.

Authors:  Maria Lucia Specchia; Andrea Di Pilla; Martina Sapienza; Maria Teresa Riccardi; Americo Cicchetti; Gianfranco Damiani; Instant Report Group
Journal:  Int J Environ Res Public Health       Date:  2021-05-09       Impact factor: 3.390

9.  Using Machine Learning Algorithms to Develop a Clinical Decision-Making Tool for COVID-19 Inpatients.

Authors:  Abhinav Vepa; Amer Saleem; Kambiz Rakhshan; Alireza Daneshkhah; Tabassom Sedighi; Shamarina Shohaimi; Amr Omar; Nader Salari; Omid Chatrabgoun; Diana Dharmaraj; Junaid Sami; Shital Parekh; Mohamed Ibrahim; Mohammed Raza; Poonam Kapila; Prithwiraj Chakrabarti
Journal:  Int J Environ Res Public Health       Date:  2021-06-09       Impact factor: 3.390

Review 10.  Prolonged fecal shedding of SARS-CoV-2 in a young immunocompetent COVID-19 patient: A case report and literature overview.

Authors:  Fang Xiao; Peiqi Wan; Qiuling Wei; Guiyang Wei; Yanhong Yu
Journal:  J Med Virol       Date:  2022-03-22       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.